Literature DB >> 1659489

Excitatory amino acids: new tools for old stories or pharmacological subtypes of glutamate receptors: electrophysiological studies.

D Lodge1, M G Jones, A J Palmer.   

Abstract

Although the N-methyl-D-aspartate (NMDA) subtype of L-glutamate receptor is well characterized, the significance of non-NMDA glutamate-sensitive binding sites is not well documented. In this study, a new tricyclic quinoxalinedione (NBQX) and an arthropod toxin (philanthotoxin) were shown to block responses of spinal neurones in vivo to kainate, quisqualate, and AMPA in parallel but had little effect on responses to NMDA. Philanthotoxin appeared to be a use-dependent antagonist consistent with a channel-blocking mode of action. On cortical wedges in vitro, however, NBQX proved to be a more potent antagonist of AMPA and quisqualate than of kainate (pA2 values of 7.1, 7.0, and 5.6, respectively) with no effect at 10 microM on responses to NMDA. These studies provide evidence that on cortical neurones, but not on spinal neurones. AMPA and kainate depolarize by pharmacologically different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659489     DOI: 10.1139/y91-164

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  4 in total

1.  Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro.

Authors:  S Zeman; D Lodge
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

2.  Excitatory amino acid receptor-stimulated phosphoinositide turnover in primary cerebrocortical cultures.

Authors:  G J Birrell; F W Marcoux
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

3.  A comparison of the actions of agonists and antagonists at non-NMDA receptors of C fibres and motoneurones of the immature rat spinal cord in vitro.

Authors:  P Pook; F Brugger; N S Hawkins; K C Clark; J C Watkins; R H Evans
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

4.  A comparison of intravenous NBQX and GYKI 53655 as AMPA antagonists in the rat spinal cord.

Authors:  B A Chizh; M J Cumberbatch; P M Headley
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.